NIOX Group (LON:NIOX) Shares Up 1.8% – Should You Buy?

NIOX Group Plc (LON:NIOX) shares shot up 1.8% during trading on Friday . The company traded as high as GBX 67.60 and last traded at GBX 67.20. 1,067,430 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 816,665 shares. The stock had previously closed at GBX 66.

NIOX Group Stock Performance

The company has a market cap of £282.82 million, a price-to-earnings ratio of 40.98 and a beta of 0.92. The company has a debt-to-equity ratio of 1.36, a quick ratio of 1.94 and a current ratio of 3.81. The company has a fifty day moving average of GBX 64.44 and a two-hundred day moving average of GBX 61.42.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.